The Ministry of Human Resources and Social Affairs has recently completed the "Guidance Opinions on the Formation of Basic Medical Insurance Pharmaceutical Payment Standards (Consultation Draft)，Solo advice from the provincial and departments again，It is expected that the formal draft of medical insurance payment standards will be introduced with the new version of the medical insurance drug catalog at the end of December this year。Medical insurance payment standards are different from the stake betting appstake betting appprevious proportion of reimbursement，Its biggest highlight is the difference between the existing price between the medical insurance payment standard and the sales price of the hospital，Allow the hospital for retention。So here，It makes the hospital have sufficient power suppression drug prices。This policy will have a huge impact on most drug prices。

 

   & ldquo; The medical insurance payment standard will be introduced with the medical insurance directory。& rdquo; Yu Mingde, chairman of the China Medical Enterprise Management Association, told the China Securities Journal a reporter，& ldquo; The Ministry of Human Resources and Social Affairs and other national ministries and commissions formulate rules，Provincial government formulates specific policies，Make payment methods for coordinating regions。& rdquo;

 

  Dr. Gu Xuefei of the National Health and Family Planning Commission Health Development Research Center said，Medical Insurance Payment Standards also known as & ldquo; benchmark price & rdquo;，Some countries call it & ldquo; reference price & rdquo;。Medical insurance payment standards are based on the equivalent of the treatment effect and the alternative of clinical treatment，Grouping with alternative medicines，Determine the medical insurance compensation level of each group of drugs at a benchmark price。

 

   & ldquo; Strictly speaking，Medical insurance payment stake sports betting appstandard My stake betting appis not a pricing system，but a compensation mechanism，It is a policy that realizes control of drug costs by restricting the level of medical insurance compensation，By reducing the demand for high -priced drugs (from the demand) and the active price reduction of drug producers (from the supplier), the price of drugs involved in the reference pricing system。& rdquo; Gu Xuefei said。

 

  What needs to be pointed out is，& ldquo; Medical insurance payment standards & rdquo; and & ldquo; medical insurance payment price & rdquo; there are obvious differences。Yu Mingde told China Securities Journal reporter，& ldquo; The misunderstanding of medical insurance payment & rdquo; is to make the medical insurance payment directly determines the final price of the drug，This is not in line with the situation; in fact, & ldquo; medical insurance payment standards & rdquo; and the formation of the actual sales price of the medicine is not directly related。

 

   & ldquo; The mechanism of payment standards will guide medical institutions to actively press the price，Final medical institutions and drug suppliers will form a drug price that reflects the real needs of the market。& rdquo; Yu Mingde pointed out。

 

  Duan Zhengming, Director of the Medical Service Management Office of the Social Security Center of the Ministry of Human Resources and Social Security, told China Securities News a reporter，Medical insurance payment standards stake betting appare higher stake sports betting appthan the actual price of the hospital，The difference can be sent to the hospital under the circumstances of financial coordination。Visible，The biggest difference between the medical insurance payment standard and the past medical insurance payment regulations is that the medical insurance payment standard makes the medical institution more motivated to actively actively lower the drug price，Therefore, it can gradually alleviate the payment pressure of the medical insurance fund。

 

  Due to the implementation of medical insurance payment standards，Pharmaceutical manufacturers will face more obvious price reduction pressure than ever。

 

  Industry insiders told China Securities Journal reporter，For those innovative medicines that are better or difficult to replace，Price reduction pressure will not be too great，High -priced drugs with more alternatives will face very large price reduction pressures，For example, the imported medicine of imported the consistency evaluation of generic drugs、Chinese medicine exclusive varieties with more Chinese medicines with more manufacturers and even some competition alternatives will face greater price reduction pressures。